Dr. Cavazzoni, who left the FDA in January, will oversee regulatory, safety and medical operations at Pfizer.
She had led the FDA’s drug division, which oversees new therapy approvals, since 2020. Dr. Cavazzoni’s appointment also marks a return to Pfizer, where she had held senior vice president roles for about eight years, according to her LinkedIn page.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.